Skip NavigationSkip to Content

Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy

  1. Author:
    Read, S. W.
    Higgins, J.
    Metcalf, J. A.
    Stevens, R. A.
    Rupert, A.
    Nason, M. C.
    Lane, H. C.
    Sereti, I.
  2. Author Address

    NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA. Sci Applicat Int Corp, AIDS Monitoring Lab, Clin Serv Program, Frederick, MD USA.;Read, SW, NIAID, Immunoregulat Lab, NIH, Rm 11B05,Bldg 10,10 Ctr Dr,MSC 1876, Bethesda, MD 20892 USA.;readsa@niaid.nih.gov
    1. Year: 2006
    2. Date: Aug
  1. Journal: Jaids-Journal of Acquired Immune Deficiency Syndromes
    1. 42
    2. 5
    3. Pages: 537-544
  2. Type of Article: Article
  3. ISSN: 1525-4135
  1. Abstract:

    Background: The interleukin-7 (IL-7)/IL-7 receptor a (IL-7R alpha) system is an important regulator of T-cell homeostasis. We evaluated the IL-7/IL-7R alpha system in a large cohort of HIV-infected patients, including a subset treated with intermittent IL-2. Methods: IL-7 serum levels and CD127 (IL-7R alpha) expression on T cells were evaluated in a cross-sectional study of 36 healthy volunteers, 151 HIV-infected patients, and 83 HIV-infected patients who had received IL-2 therapy. Multivariate regression models were used to determine predictors of CD127 expression. Results: HIV-infected patients had higher IL-7 levels compared with healthy volunteers (P = 0.022) and IL-2-treated patients (P = 0.012). CD 127 expression was significantly lower on CD4 and CD8 T cells of HIV-infected patients compared with healthy volunteers (P = 0.008 and P < 0.001, respectively), and CD127 median fluorescence intensity was lowest on CD4 T cells in IL-2-treated patients (P < 0.001 compared with HIV-infected patients). The proportion of naive and effector memory/effector T cells were significant predictors of CD127 expression on T cells. IL-2 immunotherapy led to the expansion of a CD25(+)/CD127-low subset of CD4 T cells. Conclusions: CD127 expression on T cells remains low in HIV-infected patients despite antiretroviral therapy, reflecting persistent aberration in the subset composition of the T-cell pool.

    See More

External Sources

  1. WOS: 000239444100003

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel